Prevention of cycloheximide-induced apoptosis in hepatocytes by adenosine and by caspase inhibitors

Biochemical Pharmacology

Volumn 58, Issue 12, 1999, Pages 1891-1898

  Blom, W Marty ^a   De Bont, Hans J G M ^a   Meijerman, Irma ^a   Mulder, Gerard J ^a   Nagelkerke, J Fred ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Adenosine; Apoptosis; Caspases; Cycloheximide; Liver; Mitochondria

Indexed keywords

8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; ADENOSINE; CASPASE 3; CASPASE INHIBITOR; CYCLOHEXIMIDE; PHOSPHATIDYLSERINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MEMBRANE POTENTIAL; CHROMATIN CONDENSATION; ENZYME ACTIVATION; LIVER CELL; MALE; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE; ANIMALS; APOPTOSIS; CASPASES; CYCLOHEXIMIDE; DRUG INTERACTIONS; ENZYME INHIBITORS; LIVER; MALE; MEMBRANE POTENTIALS; MITOCHONDRIA, LIVER; PROTECTIVE AGENTS; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, WISTAR;

EID: 0032700281     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00268-3     Document Type: Article

References (44)

1. Martin S.J., Lennon S.V., Bonham A.M., Cotter T.G. Induction of apoptosis (programmed cell death) in human leukemic HL 60 cells by inhibition of RNA or protein synthesis. J Immunol. 145:1990;1859-1867.
2. Meisenholder G.W., Martin S.J., Green D.R., Nordberg J., Babior B.M., Gottlieb R.A. Events in apoptosis. Acidification is downstream of protease activation and BCL-2 protection. J Biol Chem. 271:1996;16260-16262.
3. Faa G., Ledda Columbano G.M., Ambu R., Congiu T., Coni P., Riva A., Columbano A. An electron microscopic study of apoptosis induced by cycloheximide in rat liver. Liver. 14:1994;270-278.
4. Alessenko A.V., Boikov P.Y., Filippova G.N., Khrenov A.V., Loginov A.S., Makarieva E.D. Mechanisms of cycloheximide-induced apoptosis in liver cells. FEBS Lett. 416:1997;113-116.
5. Lacronique V., Mignon A., Fabre M., Viollet B., Rouquet N., Molina T., Porteu A., Henrion A., Bouscary D., Varlet P., Joulin V., Kahn A. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med. 2:1996;80-86.
6. Alessenko A.V., Korobko V.G., Khrenov A.V., Rozhnova U.A., Soloviev A.S., Shingarova L.N. Relation of biological activity of mutant forms of recombinant human tumor necrosis factor alpha and accumulation of sphingosine in murine liver. Biochem Mol Biol Int. 42:1997;143-154.
7. Jones R.A., Johnson V.L., Buck N.R., Dobrota M., Hinton R.H., Chow S.C., Kass G.E.N. Fas-mediated apoptosis in mouse hepatocytes involves the processing and activation of caspases. Hepatology. 27:1998;1632-1643.
8. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria A primary site for Bcl-2 regulation of apoptosis . Science. 275:1997;1132-1136.
9. Susin S.A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A., Daugas E., Geuskens M., Kroemer G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med. 184:1996;1331-1341.
10. Cronstein B. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol. 76:1994;5-13.
11. Ely S.W., Berne R.M. Protective effects of adenosine in myocardial ischemia. Circulation. 85:1992;893-904.
12. Mullane K., Bullough D. Harnessing an endogenous cardioprotective mechanism Cellular sources and sites of action of adenosine . J Mol Cell Cardiol. 27:1995;1041-1054.
13. Wakade T.D., Palmer K.C., McCauley R., Przywara D.A., Wakade A.R. Adenosine-induced apoptosis in chick embryonic sympathetic neurons A new physiological role for adenosine . J Physiol (Lond). 488:1995;123-138.
14. Abbracchio M.P., Ceruti S., Barbieri D., Franceschi C., Malorni W., Biondo L., Burnstock G., Cattabeni F. A novel action for adenosine Apoptosis of astroglial cells in rat brain primary cultures . Biochem Biophys Res Commun. 21:1995;908-915.
15. (2+)-mediated mechanisms. Biochem J. 304:1994;877-885.
16. Kizaki H., Suzuki K., Tadakuma T., Ishimura Y. Adenosine receptor-mediated accumulation of cyclic AMP-induced T-lymphocyte death through internucleosomal DNA cleavage. J Biol Chem. 265:1990;5280-5284.
17. Tanaka Y., Yoshihara K., Tsuyuki M., Kamiya T. Apoptosis induced by adenosine in human leukemia HL 60 cells. Exp Cell Res. 213:1994;242-252.
18. Kohno Y., Sei Y., Koshiba M., Kim H.O., Jacobson K.A. Induction of apoptosis in HL 60 human promyelocytic leukemia cells by adenosine A(3) receptor agonists. Biochem Biophys Res Commun. 219:1996;904-910.
19. Dawicki D.D., Chatterjee D., Wyche J., Rounds S. Extracellular ATP and adenosine cause apoptosis of pulmonary artery endothelial cells. Am J Physiol. 273:1997;L485-L494.
20. Nagelkerke J.F., Barto K.P., van Berkel T.J. In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer and parenchymal cells. J Biol Chem. 258:1983;12221-12227.
21. Zoetewey J.P., van de Water B., de Bont H.J.G.M., Mulder G.J., Nagelkerke J.F. Calcium-induced cytotoxicity in hepatocytes after exposure to extracellular ATP is dependent on inorganic phosphate. J Biol Chem. 268:1993;3384-3388.
22. Blom W.M., de Bont H.J.G.M., Meijerman I., Kuppen P.J.K., Mulder G.J., Nagelkerke J.F. Interleukin-2-activated natural killer cells can induce both apoptosis and necrosis in rat hepatocytes. Hepatology. 29:1999;785-792.
23. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
24. Wakade A.R., Kulkarni J.S., Fujii J.T. 2′-Deoxyadenosine selectively kills nonneuronal cells without affecting survival and growth of chick dorsal root ganglion neurons. Brain Res. 788:1998;69-79.
25. Klotz K.N., Hessling J., Hegler J., Owman C., Kull B., Fredholm B.B., Lohse M.J. Comparative pharmacology of human adenosine receptor subtypes-characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol. 357:1998;1-9.
26. Meijerman I., Blom W.M., de Bont H.G.J.M., Mulder G.J., Nagelkerke J.F. Induction of apoptosis and changes in nuclear G-actin are mediated by different pathways The effect of inhibitors of protein and RNA synthesis in isolated rat hepatocytes . Toxicol Appl Pharmacol. 156:1999;46-55.
27. Sanchez A., Alvarez A.M., Benito M., Fabregat I. Cycloheximide prevents apoptosis, reactive oxygen species production, and glutathione depletion induced by transforming growth factor beta in fetal rat hepatocytes in primary culture. Hepatology. 26:1997;935-943.
28. Zhivotovsky B., Burgess D.H., Vanags D.M., Orrenius S. Involvement of cellular proteolytic machinery in apoptosis. Biochem Biophys Res Commun. 230:1997;481-488.
29. Fernandes-Alnemri T., Armstrong R.C., Krebs J., Srinivasula S.M., Wang L., Bullrich F., Fritz L.C., Trapani J.A., Tomaselli K.J., Litwack G., Alnemri E.S. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA. 93:1996;7464-7469.
30. Orth K., O'Rourke K., Salvesen G.S., Dixit V.M. Molecular ordering of apoptotic mammalian CED-3/ICE-like proteases. J Biol Chem. 271:1996;20977-20980.
31. Hirata H., Takahashi A., Kobayashi S., Yonehara S., Sawai H., Okazaki T., Yamamoto K., Sasada M. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med. 187:1998;587-600.
32. Kuida K., Lippke J.A., Ku G., Harding M.W., Livingston D.J., Su M.S., Flavell R.A. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science. 267:1995;2000-2003.
33. Kuida K., Zheng T.S., Na S., Kuan C., Yang D., Karasuyama H., Rakic P., Flavell R.A. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature. 384:1996;368-372.
34. Zamzami N., Marchetti P., Castedo M., Hirsch T., Susin S.A., Masse B., Kroemer G. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett. 384:1996;53-57.
35. Boise L.H., Thompson C.B. Bcl x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc Natl Acad Sci USA. 94:1997;3759-3764.
36. Backway K.L., McCulloch E.A., Chow S., Hedley D.W. Relationships between the mitochondrial permeability transition and oxidative stress during ara-C toxicity. Cancer Res. 57:1997;2446-2451.
37. Walker B.A., Rocchini C., Boone R.H., Ip S., Jacobson M.A. Adenosine A2a receptor activation delays apoptosis in human. J Immunol. 158:1997;2926-2931.
38. Yao Y., Sei Y., Abbracchio M.P., Jiang J.L., Kim Y.C., Jacobson K.A. Adenosine A3 receptor agonists protect HL 60 and U 937 cells from apoptosis induced by A3 antagonists. Biochem Biophys Res Commun. 232:1997;317-322.
39. Lund P., Cornell N.W., Krebs H.A. Effect of adenosine on the adenine nucleotide content and metabolism of hepatocytes. Biochem J. 152:1975;593-599.
40. Kass G.E.N., Eriksson J.E., Weis M., Orrenius S., Chow S.C. Chromatin condensation during apoptosis requires ATP. Biochem J. 318:1996;749-752.
41. Kluck R.M., Martin S.J., Hoffman B.M., Zhou J.S., Green D.R., Newmeyer D.D. Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J. 16:1997;4639-4649.
42. Vanags D.M., Pörn-Ares M.I., Coppola S., Burgess D.H., Orrenius S. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J Biol Chem. 271:1996;31075-31085.
43. Garland J.M., Halestrap A. Energy metabolism during apoptosis. Bcl-2 promotes survival in hematopoietic cells induced to apoptose by growth factor withdrawal by stabilizing a form of metabolic arrest. J Biol Chem. 272:1997;4680-4688.
44. Leist M., Single B., Castoldi A.F., Kuhnle S., Nicotera P. Intracellular adenosine triphosphate (ATP) concentration A switch in the decision between apoptosis and necrosis . J Exp Med. 185:1997;1481-1486.